Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

54.20
Delayed Data
As of Sep 01
 -1.07 / -1.94%
Today’s Change
41.72
Today|||52-Week Range
60.34
+28.07%
Year-to-Date

Today’s Trading

Previous close55.27
Today’s open54.24
Day’s range53.97 - 54.53
Volume1,068,838
Average volume (3 months)1,337,664
Market cap$110.9B
Dividend yield1.40%
Data as of 4:03pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+5.60%
P/E ratio4.5
Price/Sales7.07
Price/Book21.89

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-1.91-3.06%
AGNAllergan-9.53-3.14%
GSKGlaxoSmithKline-1.46-3.57%
BMYBristol-Myers Squibb-1.27-2.14%
Data as of 4:03pm ET, 09/01/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$0.46
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Gladsaxe, Capital Region

Forecasts

Partner Offers